Compare XERS & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | BXMT |
|---|---|---|
| Founded | 2005 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2021 | 1998 |
| Metric | XERS | BXMT |
|---|---|---|
| Price | $13.32 | $11.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $12.86 | ★ $15.21 |
| AVG Volume (30 Days) | 2.2M | ★ 3.6M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 10.32% |
| EPS Growth | 100.00 | ★ 154.70 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $32.91 | N/A |
| Revenue Next Year | $23.75 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $5.25 | $10.12 |
| 52 Week High | $11.42 | $20.67 |
| Indicator | XERS | BXMT |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 57.19 |
| Support Level | $9.73 | $10.12 |
| Resistance Level | $10.60 | $14.27 |
| Average True Range (ATR) | 0.48 | 0.41 |
| MACD | -0.09 | 0.21 |
| Stochastic Oscillator | 39.36 | 99.34 |
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.